Evidence map›Paper›PMID 41952680›Full record

ArticleFrontiers in oncology2026

Correction: Recent therapeutic advances in gynecologic oncology: evolving roles of immunotherapy, antibody-drug conjugates, and clinical trial innovations.

Gaukhar Koshkimbayeva, Akerke Amirkhanova, Aiken Orazymbetova, Alma Nurakhova, Akmaral Maimakova, Altyn Duisenbayeva, Nurgulim Akhmad, Altyn Abilova, Arailym Abilbayeva, Sholpan Akhelova and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Gaukhar KoshkimbayevaDepartment of General Medical Practice with Courses, Kazakh-Russian Medical University, Almaty, Kazakhstan.
Akerke AmirkhanovaSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Aiken OrazymbetovaDepartment of Anatomy with Courses, Kazakh-Russian Medical University, Almaty, Kazakhstan.
Alma NurakhovaDepartment of Normal Physiology with a course in Biophysics, School of Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Akmaral MaimakovaClinical Medicine Department of International Business, University named after Kenzhegali Sagadiev, Almaty, Kazakhstan.
Altyn DuisenbayevaDepartment of Anatomy named after S. R. Karynbayev, School of General Medicine 1, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Nurgulim AkhmadGeneral Immunology Department, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Altyn AbilovaGeneral Immunology Department, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Arailym AbilbayevaGeneral Immunology Department, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Sholpan AkhelovaDepartment of Pharmaceutical Disciplines, NCJSC "Astana Medical University", Astana, Kazakhstan.
Dana AkhmentayevaDepartment of Internal Medicine, S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Aida SeitaliyevaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Zaure DushimovaFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Zhanserik ShynykulFaculty of Medicine and Healthcare, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Sandugash YerkenovaDepartment of Anatomy, Kazakhstan's Medical University "KSPH", Almaty, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2025.1697180.].

Indexed as

antibody–drug conjugatescancercervical cancerendometrial cancergynecologic malignanciesimmune checkpoint inhibitorsovarian cancer

Identifiers

PMID41952680
PMCPMC13054803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.